Navigation Links
Biomedical research revealing secrets of cell behavior
Date:7/1/2013

TEMPE, Ariz -- Knowing virtually everything about how the body's cells make transitions from one state to another for instance, precisely how particular cells develop into multi-cellular organisms would be a major jump forward in understanding the basics of what drives biological processes.

Such a leap could open doors to far-reaching advances in medical science, bioengineering and related areas.

An interdisciplinary team of researchers at Arizona State University, with a partner at Imperial College London, report on taking at least a step toward better comprehension of the fundamentals of "cell fate determination" in the prominent research journal Proceedings of the National Academy of Sciences (PNAS).

Cell fate determination relates to the mechanisms by which a cell "decides" in what direction it will go in moving through transitional phases into a final state.

Using mathematical modeling and synthetic biology techniques the team is manufacturing artificial gene networks (a collection of DNA segments in a cell that interact with each other) and introducing them into cells in the laboratory.

From there, the researchers are able to closely observe through microscopic imaging what is happening with particular cells at their "tipping point," a stage of rest right before they transition into other states.

By learning what takes place at that point, "We can get closer to a fundamental insight about all biology," says biomedical engineer and synthetic biologist Xiao Wang.

Once the mechanisms determining the fate of cells are better understood, Wang says, "We could make gene networks or devices that do what we want them to do," such as create cells that produce medicinal drugs or that kill diseased cells, or create cells that act as sensors to detect environmental hazards.

Wang is an assistant professor in the School of Biological and Health Systems Engineering, one of ASU's Ira A. Fulton Schools of Engineering. He is the senior author of the PNAS paper.

Wang's fellow authors are: biomedical engineering research scientists Min Wu and Xiaohui Li, who work in Wang's lab; electrical engineering graduate student Ri-Qi Su; Ying-Cheng Lai, a professor in ASU's School of Electrical, Computer and Energy Engineering; and synthetic biologist Tom Ellis from Imperial College London.

Their article, "Engineering of regulated stochastic cell fate determination," is available online at http://www.pnas.org.ezproxy1.lib.asu.edu/content/110/26/10610.full

The research team is studying the molecular-level interactions within the DNA sequences of cells, through which the products of one gene affect those of other genes. This helps to trace the lineages of cell development and reveal what drives them in the direction of what kinds of cells they will be in their final states.

Within deeper knowledge of the workings of such processes lays the key to more effectively engineering cells and gene networks.

Wang's team is focused on investigating the intricate properties of gene networks with the goal of learning new ways of regulating the mechanisms behind cell fate determination.

"Our research could be built upon to look at more complicated gene networks and more complex cellular behavior," paving the way for expanding the capabilities of bioengineering to protect and maintain human health, Wang says.


'/>"/>

Contact: Joe Kullman
joe.kullman@asu.edu
480-965-8122
Arizona State University
Source:Eurekalert

Related biology news :

1. New FASEB analysis documents impact of budget cuts on biomedical research
2. Core for Life, a new European alliance in biomedical research
3. WPI Biomedical Technology in final 4 of international business plan contest
4. Breakthrough study opens door to broader biomedical applications for Raman spectroscopy
5. Vilcek Prize for Biomedical Science split between 2 giants of immunology
6. 12th annual Wiley Prize in Biomedical Sciences awarded
7. Wiley Prize in Biomedical Sciences awarded to Rosbash, Hall and Young
8. Improving the development of new cancer models using an advanced biomedical imaging method
9. Lyncean Technologies Inc. sells Compact Light Source to Munich biomedical-imaging research center
10. FASEB urges biomedical research community to speak out against sequestration
11. US investment in biomedical and health research on downward trend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... PUNE, India , March 23, 2017 The report ... Equipment, Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by ... growing at a CAGR of 29.63% between 2017 and 2022. ... ... Logo ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , March ... Made Simple," and 23andMe , the leading personal ... food choices.  Zipongo can now provide customers with personalized ... health goals and biometrics, but also genetic markers impacting ... Zipongo,s personalized food decision support platform uses ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... -- The new research portal will give visitors ... on Valero Energy , offering extensive market research on ... ... http://photos.prnewswire.com/prnh/20160330/349511LOGO) The latest trend gaining momentum ... today, even though touted as a green alternative to fossil ...
(Date:3/27/2017)... , March 27, 2017 DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... coverage option for U.S. consumers who want to have ... DarioHealth has signed strategic alliance agreements with partners across ... coverage benefits, and if approved, will supply and bill ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... Business Report" report to their offering. ... This report analyzes the Global market ... estimates and forecasts are provided for the period 2014 through 2022. ... The report profiles 25 companies including many key ...
(Date:3/24/2017)... Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company ... vaccines, today announced participation at the following conferences: ... and Maidstone Life Sciences conference "Cancer Immunotherapy Conference" at ... New York, NY . Agenus will participate in ... am: Robert B. Stein , M.D., Ph.D., President, ...
Breaking Biology Technology: